Bharat Biotech, Biovet, Sapigen partners with CSIR-IICT to develop indigenous vaccines

The industry collaborators shall provide necessary financial support to CSIR-IICT.

Bharat Biotech International, Biovet, and Sapigen Biologix on Monday signed a joint Master Collaborative Agreement (MCA) with CSIR-Indian Institute of Chemical Technology (CSIR-IICT), in a move to support indigenous development of novel platform technologies for bio-therapeutics and vaccines.


Bharat Biotech said that the collaborators will identify the mutually interesting projects to pursue under the agreement.


As part of this collaboration, the industry collaborators shall provide necessary financial support to CSIR-IICT to develop key raw materials required by the collaborators and perform in-vitro and in vivo studies for further development of potential vaccine candidates and bio-therapeutics formulations to be designed by the collaborators.


The broad-based MCA enables the partners to take up futuristic development activities in other related areas as well.


The MCA was signed in presence of CSIR Director General Dr Shekhar C. Mande, and Bharat Biotech CMD, Dr Krishna M. Ella, by Bharat Biotech Executive Director, Dr Krishna Mohan, Biovet Director, Dr Jalachari Ella, Sapigen Biologix Director, Dr Raches Ella, and CSIR-IICT’s Dr. S Chandrasekhar.

India Scanner News Network

Leave a comment